He Xiaoqi, Sun Tianwei, Wang Jizhou, Li Guang, Fei Qiaoman
Graduate School of Tianjin Medical University.
Department of Spinal Surgery, Tianjin Union Medical Center, Tianjin, People's Republic of China.
Clin Spine Surg. 2019 May;32(4):150-163. doi: 10.1097/BSD.0000000000000778.
This was a meta-analysis study.
Our meta-analysis study aimed to evaluate the efficacy of vancomycin powder to reduce the surgical site infection (SSI) in spinal surgery.
The SSI is a potential and devastating complication after spinal surgery. Local application of vancomycin powder is an attractive adjunctive therapy to reduce SSI in spinal surgery.
Studies were identified from PubMed, The Cochrane Library, AMED, Web of Science, Scopus, Ovid, EMBASE, and Ebsco Medline. The fixed-effects model was used to compute the merge of relative risk and 95% confidence interval (CI). Heterogeneity tests were checked by I statistics. Subgroup analysis was performed to determine whether vancomycin powder was beneficial, that could reduce the SSI in spinal surgery, or not. Publication bias was explored by funnel plot.
We included 21 studies for final analysis. In our analysis, application of vancomycin powder was associated with a significantly reduced risk of SSI and deep SSI. Pooled relative risks showed significant changes: SSI, 0.36 (95% CI: 0.27-0.47, P=0.000), SSI in the instrumented group, 0.35 (95% CI: 0.25-0.49, P=0.000), SSI in the noninstrumented group, 0.39 (95% CI: 0.24-0.65, P=0.000), deep SSI, 0.28 (95% CI: 0.18-0.44, P=0.000), and the incidence pseudoarthrosis, 0.88 (95% CI: 0.35-2.21, P=0.784). In the subgroup analysis, vancomycin powder showed beneficial effects to SSI in the instrumented group. Pooled the heterogeneity: SSI (P=0.124, I=30.0%), SSI in the instrumented group (P=0.366, I=8.2%), SSI in the noninstrumented group (P=0.039, I=60.5%), deep SSI (P=0.107, I=33.5%).
The application of vancomycin powder could decrease the SSI and deep SSI in spinal surgery. In the subgroup, vancomycin powder is beneficial to the SSI in the instrumented group. The available evidence is too limited to make the conclusion that the use of vancomycin powder causes pseudoarthrosis in spinal surgery, its extrapolation should be carefully executed.
这是一项荟萃分析研究。
我们的荟萃分析旨在评估万古霉素粉末在脊柱手术中降低手术部位感染(SSI)的疗效。
SSI是脊柱手术后一种潜在的严重并发症。局部应用万古霉素粉末是一种有吸引力的辅助治疗方法,可减少脊柱手术中的SSI。
从PubMed、Cochrane图书馆、AMED、科学网、Scopus、Ovid、EMBASE和Ebsco Medline中检索研究。采用固定效应模型计算相对风险合并值和95%置信区间(CI)。通过I统计量进行异质性检验。进行亚组分析以确定万古霉素粉末是否有益,即能否降低脊柱手术中的SSI。通过漏斗图探讨发表偏倚。
我们纳入了21项研究进行最终分析。在我们的分析中,应用万古霉素粉末与SSI和深部SSI风险显著降低相关。合并相对风险显示出显著变化:SSI为0.36(95%CI:0.27 - 0.47,P = 0.000),器械植入组的SSI为0.35(95%CI:0.25 - 0.49,P = 0.000),非器械植入组的SSI为0.39(95%CI:0.24 - 0.65,P = 0.000),深部SSI为0.28(95%CI:0.18 - 0.44,P = 0.000),假关节发生率为0.88(95%CI:0.35 - 2.21,P = 0.784)。在亚组分析中,万古霉素粉末对器械植入组的SSI显示出有益效果。合并异质性:SSI(P = 0.124,I = 30.0%),器械植入组的SSI(P = 0.366,I = 8.2%),非器械植入组的SSI(P = 0.039,I = 60.5%),深部SSI(P = 0.107,I = 33.5%)。
万古霉素粉末的应用可降低脊柱手术中的SSI和深部SSI。在亚组中,万古霉素粉末对器械植入组的SSI有益。现有证据有限,无法得出在脊柱手术中使用万古霉素粉末会导致假关节的结论,对其外推应谨慎进行。